Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2017 (2017), Article ID 7217619, 8 pages
https://doi.org/10.1155/2017/7217619
Research Article

Anxiolytic Effect of Citrus aurantium L. in Crack Users

1Postgraduate Program in Neuroscience Cognitive and Behavior, Federal University of Paraíba, João Pessoa, PB, Brazil
2Department of Nursing and Collective Health, Federal University of Paraíba, João Pessoa, PB, Brazil
3Postgraduate Program in Natural and Synthetic Bioactive Products, Federal University of Paraíba, João Pessoa, PB, Brazil
4Institute of Research in Drugs and Medicines, Federal University of Paraíba, João Pessoa, PB, Brazil

Correspondence should be addressed to Mateus Feitosa Alves; moc.liamg@sevlafsuetam

Received 5 April 2017; Accepted 7 September 2017; Published 18 October 2017

Academic Editor: Heba Abdelhalim

Copyright © 2017 Gabriel Chaves Neto et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. A. Mombelli, S. S. Marcon, and J. B. Costa, “Characterization of psychiatric admissions for detoxification of drug addicted adolescents,” Revista Brasileira de Enfermagem, vol. 63, no. 5, pp. 735–740, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. M. L. O. S. Formigoni, (Cord.) SUPERA: System for detection of abuse and dependence of psychoactive substances: referral, brief intervention, and social integration and follow-up. Effects of psychoactive substances, Ministry of Justice: National Secretariat for Drug Policy, 2014.
  3. T. C. de Zeni and R. B. Araujo, “Relationship between craving for tobacco and craving for crack in patients hospitalized for detoxification,” Jornal Brasileiro de Psiquiatria, vol. 60, no. 1, pp. 28–33, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. Brazilian Association of Psychiatry, “Abuse and dependence: crack,” Journal of the Brazilian Medical Association, vol. 58, no. 2, pp. 138–140, 2012. View at Google Scholar
  5. J. E. F. Braga, L. C. Pourdes, A. T. M. C. Silva, F. C. F. Pimenta, M. F. F. Diniz, and R. N. Almeida, “Pathological anxiety: neural bases and advances in the psychopharmacological approach,” Revista Brasileira de CiΩncias da Saude, vol. 14, no. 2, pp. 93–100, 2010. View at Google Scholar
  6. J. E. F. Braga, Clinical Pharmacological Trials with and Root Extract of Panaxginseng C. A. Meyer in the control of anxiety [Ph.D. thesis], Federal University of Paraíba, Paraíba, Brazil.
  7. C. S. Lyra, L. S. Nakai, and A. P. Marques, “Effectiveness of aromatherapy in reducing stress and anxiety levels in undergraduate health science students: a preliminary study,” Fisioterapia e Pesquisa, vol. 17, no. 1, pp. 13–17, 2010. View at Publisher · View at Google Scholar
  8. T. C. Goes, F. D. Antunes, P. B. Alves, and F. Teixeira-Silva, “Effect of sweet orange aroma on experimental anxiety in humans,” The Journal of Alternative and Complementary Medicine, vol. 18, no. 8, pp. 798–804, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. T. T. Faustino, R. B. De Almeida, and R. Andreatini, “Medicinal plants for the treatment of generalized anxiety disorder: A review of controlled clinical studies,” Revista Brasileira de Psiquiatria, vol. 32, no. 4, pp. 429–436, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. C. A. R. A. Costa, T. C. Cury, B. O. Cassettari, R. K. Takahira, J. C. Flório, and M. Costa, “Citrus aurantium L. essential oil exhibits anxiolytic-like activity mediated by 5-HT1A-receptors and reduces cholesterol after repeated oral treatment,” BMC Complementary and Alternative Medicine, vol. 13, article 42, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. F. C. F. Pimenta, M. F. Alves, M. B. F. Pimenta et al., “Anxiolytic Effect of Citrus aurantium L. on Patients with Chronic Myeloid Leukemia,” Phytotherapy Research, vol. 30, no. 4, pp. 613–617, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. A. T. Henriques, C. Simões-Pires, and M. A. Apel, “Essential Oils: Importance and Therapeutic Perspectives,” in Chemistry of natural products, new drugs and modern pharmacognosy, A. R. Yunes. and V. Cechinel Filho, Eds., vol. 2, pp. 221–252, University of the Itajaí Valley, 2009. View at Google Scholar
  13. A. M. Pultrini, L. A. Galindo, and M. Costa, “Effects of the essential oil from Citrus aurantium L. in experimentalanxiety models in mice,” Life Sciences, vol. 78, pp. 1720–1725, 2006. View at Google Scholar
  14. M. P. Leite, J. Fassin Jr., E. M. F. Baziloni, R. N. Almeida, R. Mattei, and J. R. Leite, “Behavioral effects of essential oil of Citrus aurantium L. inhalation in rats,” Revista Brasileira de Farmacognosia, vol. 18, pp. 661–666, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. R. P. Adams, Identification of Essential Oil Components by Gas Chromatography/Mass Spectroscopy, Allured Publishing Corporation, Carol Stream, Ill, USA, 1995. View at Publisher · View at Google Scholar
  16. G. Chaves Neto, Effect of Citrus Aurantium L. essential oil on anxiety levels in crack users. Dissertation [MSc. thesis], Federal University of Paraíba, João Pessoa, Brazil, 2016.
  17. M. I. R. Carvalho-Freitas and M. Costa, “Anxiolytic and Sedative Effects of Extracts and Essential Oil from Citrus aurantium L,” Biol. Pharm. Bull, vol. 25, no. 12, pp. 1629–1633, 2002. View at Google Scholar
  18. Ministry of Health, Hospital Infection Control Coordination, Processing of articles and surfaces in health facilities, Ministry of Health, 2003.
  19. F. S. Guimarães, A. W. Zuardi, and F. G. Graeff, “Effect of chlorimipramine and maprotiline on experimental anxiety in humans,” Journal of Psychopharmacology, vol. 1, no. 3, pp. 184–192, 1987. View at Publisher · View at Google Scholar · View at Scopus
  20. C. D. Spielbergert, R. I. Gorsuch, and R. E. Lushene, Manual for the State-Trait Anxiety Inventory, Consulting Psychologists Press, 1970.
  21. A. M. B. Biaggio and L. Natalício, “Manual for the Trait-State Anxiety Inventory (IDATE),” in Rio de Janeiro: Center of Applied Psychology (CEPA), 1979. View at Google Scholar
  22. H. Norris, “The action of sedatives on brain stem oculomotor systems in man,” Neuropharmacology, vol. 10, no. 2, pp. 181–191, 1971. View at Publisher · View at Google Scholar · View at Scopus
  23. A. W. Zuardi and I. G. Karniol, “Transcultural study of a self-assessment scale for subjective states,” Brazilian Journal of Psychiatry, vol. 30, no. 5, pp. 403–406, 1981. View at Google Scholar
  24. A. R. B. Hess, R. M. M. de Almeida, and A. L. Moraes, “Psychiatric comorbidities in abstinent drug addict in a protected environment,” Estudos de Psicologia, vol. 17, no. 1, pp. 171–178, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Zubaran, K. Foresti, M. R. Thorell, and P. R. Franceschini, “Anxiety symptoms in crack cocaine and inhalant users admitted to a psychiatric hospital in southern Brazil,” Revista da Associação Médica Brasileira, vol. 59, no. 4, pp. 360–367, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. M. J. Herrero, A. Domingo-Salvany, M. Torrens et al., “Psychiatric comorbidity in young cocaine users: Induced versus independent disorders,” Addiction, vol. 103, no. 2, pp. 284–293, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Sareen, M. Chartier, M. P. Paulus, and M. B. Stein, “Illicit drug use and anxiety disorders: Findings from two community surveys,” Psychiatry Research, vol. 142, no. 1, pp. 11–17, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. D. A. Regier, J. H. Boyd, J. D. Burke et al., “One-Month Prevalence of Mental Disorders in the United States: Based on Five Epidemiologic Catchment Area Sites,” Archives of General Psychiatry, vol. 45, no. 11, pp. 977–986, 1988. View at Publisher · View at Google Scholar · View at Scopus
  29. M. M. A. Gama, G. S. Moura, R. F. Araújo, and F. Teixeira-Silva, “Trait anxiety in Brazilian university students from Aracaju,” Revista de Psiquiatria do Rio Grande do Sul, vol. 30, no. 1, pp. 19–24, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. F. Kapczinski, J. Quevedo, and I. Izquierdo, Biological Bases of Psychiatric Disorders: A Translational Approach, Artmed, Porto Alegre, Brazil, 3rd edition, 2011.
  31. T. V. Chaves, Z. M. Sanchez, L. A. Ribeiro, and S. A. Nappo, “Crack cocaine craving: Behaviors and coping strategies among current and former users,” Revista de Saúde Pública, vol. 45, no. 6, pp. 1168–1175, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Lehrner, G. Marwinski, S. Lehr, P. Johren, and L. Deecke, “Ambient odors of orange and lavender reduce anxiety and improve mood in a dental office,” Physiology & Behavior, vol. 86, no. 1-2, pp. 92–95, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Akhlaghi, G. Shabanian, M. Rafieian-Kopaei, N. Parvin, M. Saadat, and M. Akhlaghi, “Citrus aurantium Blossom and Preoperative Anxiety,” Revista Brasileira de Anestesiologia, vol. 61, no. 6, pp. 702–712, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. G. S. L. Alves and R. B. Araujo, “The use of cooperative games to treat crackdependent patients hospitalized at a detoxication unit,” Revista Brasileira de Medicina do Esporte, vol. 18, no. 2, pp. 77–80, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. J. E. F. Braga, G. C. Neto, A. B. Lima, R. Q. De Oliveira, R. S. Alves, and J. A. Farias, “Cooperative games and respiratory relaxation: Effect on craving and anxiety,” Revista Brasileira de Medicina do Esporte, vol. 22, no. 5, pp. 403–407, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. P. J. Cunha, S. Nicastri, L. P. Gomes, R. M. Moino, and M. A. Peluso, “Neuropsychological impairments in crack cocaine-dependent inpatients: Preliminary findings,” Revista Brasileira de Psiquiatria, vol. 26, no. 2, pp. 103–106, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. C. Garcia-Leal, C. M. Del-Ben, F. M. Leal, F. G. Graeff, and F. S. Guimarães, “Escitalopram prolonged fear induced by simulated public speaking and released hypothalamic-pituitary-adrenal axis activation,” Journal of Psychopharmacology, vol. 24, no. 5, pp. 683–694, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. M. L. Brandão, D. M. Vianna, S. Masson, and J. Santos, “Neural organization of different types of fear: Implications for the understanding of anxiety,” Revista Brasileira de Psiquiatria, vol. 25, no. 2, pp. 36–41, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. A. A. F. Almeida, Psychophysiological and vocal alterations in individuals submitted to the public speaking simulation test [PhD. Thesis], Federal University of São Paulo, São Paulo, Brazil, 2009.
  40. K.-M. Chang and C.-W. Shen, “Aromatherapy benefits autonomic nervous system regulation for elementary school faculty in Taiwan,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 946537, 7 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus